Nevertheless, our results show that, in the absence of BRCA1-dependent HR promotion, shieldin-directed DNA end joining exacerbates DNA damage-induced chromosomal instability, where it also makes substantial contributions to the overall hypersensitivity of cancer cells to HR deficiency-targeting PARPis (Fig. 6c). The gene discussed is BRCA1; the disease is cancer.